Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum (Q37006314)

17 August 2017

1 reference

title

Monogenic pediatric dyslipidemias: classification, genetics and clinical spectrum (English)

1 reference

17 August 2017

1 reference

2

Robert A Hegele

0 references

author name string

Amit R Rahalkar

series ordinal

1

1 reference

17 August 2017

publication date

26 November 2007

1 reference

Molecular Genetics and Metabolism

17 August 2017

published in

1 reference

17 August 2017

volume

93

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

282-294

1 reference

Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Genetics of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Protease variants, LDL, and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Molecular regulation of HDL metabolism and function: implications for novel therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Clinical practice. Hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Lipoprotein atherogenicity: an overview of current mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Mechanisms of disease: genetic causes of familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

The longest-lived patient with homozygous familial hypercholesterolemia secondary to a defect in internalization of the LDL receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Homozygous familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Guidelines for the diagnosis and management of familial hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

The LDL receptor locus and the genetics of familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

A systematic review of LDL apheresis in the treatment of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Familial hypercholesterolemia—Improving treatment and meeting guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Long-term outcome after living donor liver transplantation for two cases of homozygous familial hypercholesterolemia from a heterozygous donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Identification and management of heterozygous familial hypercholesterolemia: summary and recommendations from an NHLBI workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Statin treatment in children with familial hypercholesterolemia: the younger, the better

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Genetics, clinical phenotype, and molecular cell biology of autosomal recessive hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Autosomal recessive hypercholesterolaemia: discrimination of ARH protein and LDLR function in the homozygous FH phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Current management of severe homozygous hypercholesterolaemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Wolman disease successfully treated by bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Enzyme therapy for lysosomal acid lipase deficiency in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Lysosomal acid lipase deficiency: correction of lipid storage by adenovirus-mediated gene transfer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Selective sterol accumulation in ABCG5/ABCG8-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Phenotypic heterogeneity of sitosterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Molecular diagnosis of hypobetalipoproteinemia: an ENID review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Frequency of ApoB and ApoE Gene Mutations as Causes of Hypobetalipoproteinemia in the Framingham Offspring Population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Refractory infantile diarrhea due to primary bile acid malabsorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Intestinal bile acid transport: biology, physiology, and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

SC-435, an ileal apical sodium co-dependent bile acid transporter (ASBT) inhibitor lowers plasma cholesterol and reduces atherosclerosis in guinea pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Inhibition of the intestinal absorption of bile acids using cationic derivatives: mechanism and repercussions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Unravelling the functional significance of PCSK9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Tangier disease: still more questions than answers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

THE INHERITANCE OF HIGH DENSITY LIPOPROTEIN DEFICIENCY (TANGIER DISEASE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Homozygous Tangier disease and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

ABCA1 and atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Microsomal enzyme inducers raise plasma high-density lipoprotein cholesterol levels in healthy control subjects but not in patients with primary hypoalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Differential diagnosis of familial high density lipoprotein deficiency syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

A specific apoprotein activator for lipoprotein lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Apolipoprotein C-II deficiency presenting as a lipid encephalopathy in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Hypertriglyceridemia: its etiology, effects and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Recurrent acute and chronic pancreatitis in two brothers with familial chylomicronemia syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Familial chylomicronemia syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Complete rescue of lipoprotein lipase-deficient mice by somatic gene transfer of the naturally occurring LPLS447X beneficial mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

Gene therapy for lipoprotein lipase deficiency: working toward clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2007.10.007

10.1016/J.YMGME.2007.10.007

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference